FilingSEC EDGAR8-K
Anavex Life Sciences Reports Change in Control Following Board Election
· SEC accepted
StageChange in Control
Filing content
A contested board election at the annual meeting resulted in a change in control under company incentive plans, triggering the immediate full vesting of all outstanding unvested equity awards.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…